Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures
|ClinicalTrials.gov Identifier: NCT01727843|
Recruitment Status : Unknown
Verified May 2013 by Rick Lau, Queen's University.
Recruitment status was: Recruiting
First Posted : November 16, 2012
Last Update Posted : May 14, 2013
|Condition or disease||Intervention/treatment||Phase|
|Femoral Neck Fracture||Drug: Tranexamic Acid Other: placebo||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||126 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Phase III Examining the Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures: a Randomized Control Trial.|
|Study Start Date :||April 2013|
|Estimated Primary Completion Date :||April 2014|
|Estimated Study Completion Date :||April 2014|
Experimental: tranexamic acid
3000mg/mL tranexamic acid in saline applied directly to the wound at the end of the surgical procedure.
Drug: Tranexamic Acid
drug and placebo applied topically at end of surgery at hip site.
Other Name: Cyklokapron
Placebo Comparator: saline
3000mg/mL saline applied directly to the wound at the end of the surgical procedure
applied topically to surgical site in OR.
Other Name: saline solution
- Blood loss [ Time Frame: postop 0-8 days. ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01727843
|Queen's Univeristy, KGH||Recruiting|
|Kingston, Ontario, Canada, K7L2G7|
|Contact: Grant firstname.lastname@example.org|
|Principal Investigator: Rick Lau, MD|
|Principal Investigator:||Rick Lau, MD||Queen's Univeristy|